Cargando…
Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma
BACKGROUND AND PURPOSE: Retroperitoneal sarcoma (RPS) is a rare, complex disease requiring multidisciplinary management. We have previously reported that use of the Revised Edmonton Symptom Assessment Scale (ESAS-r-CSS) allows for proactive symptom management, and we sought to report the results of...
Autores principales: | Palm, Russell F., Jim, Heather S.L., Boulware, David, Johnstone, Peter A.S., Naghavi, Arash O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063105/ https://www.ncbi.nlm.nih.gov/pubmed/32181374 http://dx.doi.org/10.1016/j.ctro.2020.02.007 |
Ejemplares similares
-
A modified Edmonton Symptom Assessment Scale for symptom clusters in radiation oncology patients
por: Johnstone, Peter A. S., et al.
Publicado: (2017) -
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
por: Li, Xiangji, et al.
Publicado: (2022) -
Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma
por: Palm, Russell F., et al.
Publicado: (2022) -
Validity and reliability of the Edmonton Frail Scale
por: Rolfson, Darryl B, et al.
Publicado: (2006) -
Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)